Linkage Global launches Phase II clinical research on non-drug cognitive impairment, sleep disorder approaches

PUBT · 2d ago
Linkage Global launches Phase II clinical research on non-drug cognitive impairment, sleep disorder approaches
  • Linkage Global launched second-stage clinical research on non-drug approaches for cognitive impairment and sleep disorders.
  • Results from an earlier two-year observational study were presented, showing some coma patients regained consciousness during follow-up.
  • Findings remain preliminary, with no controlled trial design, no peer review, and no regulator review of the protocol.
  • Program signals a push to use research data to guide product development in wellness devices aimed at clinical and consumer markets.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Linkage Global Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608250830PRIMZONEFULLFEED9815527) on August 25, 2026, and is solely responsible for the information contained therein.